KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹26 Cr | ₹0.99 Cr | ₹-20 Cr | ₹123 Cr | ₹-35 Cr |
What is the latest Cash Flow from Financing Activities ratio of KOPRAN ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹0.99 Cr |
| Mar2023 | ₹-20 Cr |
| Mar2022 | ₹123 Cr |
| Mar2021 | ₹-35 Cr |
How is Cash Flow from Financing Activities of KOPRAN Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | 2,515.57 | |
| Mar2024 | ₹0.99 Cr | Positive | |
| Mar2023 | ₹-20 Cr | Negative | |
| Mar2022 | ₹123 Cr | Positive | |
| Mar2021 | ₹-35 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹731.7 Cr | 2.2% | 4.6% | -29% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,782.0 Cr | -1% | -4.9% | -7.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,376.0 Cr | -1.3% | -1.2% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,225.0 Cr | 0.2% | 2.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹121,174.0 Cr | -0.3% | -1.1% | -0.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,629.0 Cr | -1.2% | -1.8% | -7.7% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | 2.2% |
4.6% |
-29% |
| SENSEX | -0.3% |
-0.5% |
8.3% |
You may also like the below Video Courses